Home › Research › Brain scans and imaging
Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features
Rogalski E, Sridhar J, Rader B, Martersteck A, Chen K, Cobia D, Thompson CK, Weintraub S et al.. Neurology, 2016-08-26
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To identify features of primary progressive aphasia (PPA) associated with Alzheimer disease (AD) neuropathology. A related objective was to determine whether logopenic PPA is a clinical marker for AD. Methods A total of 139 prospectively enrolled participants with a root diagnosis of PPA constituted the reference set. Those with autopsy or biomarker evidence of AD, and who had been evaluated at mild disease stages (Aphasia Quotient ≥85), were included (n = 19). All had quantitative language testing and APOE genotyping. Fifteen had MRI morphometry. Results Impaired word-finding was the universal presenting complaint in the aphasic AD group. PPA clinical subtype was logopenic (n = 13) and agrammatic (n = 6). Fluency, repetition, naming, and grammaticality ranged from preserved to severely impaired. All had relative preservation of word comprehension. Eight of the 15 aphasic participants with AD showed no appreciable cortical atrophy at the individual level on MRI. As a group, atrophy was asymmetrically concentrated in the left perisylvian cortex. APOE ε4 frequency was not elevated. Conclusions There is a close, but not obligatory, association between logopenic PPA and AD. No language measure, with the possible exception of word comprehension, can confirm or exclude AD in PPA. Biomarkers are therefore essential for diagnosis. Asymmetry of cortical atrophy and normal APOE ε4 prevalence constitute deviations from typical AD. These and additional neuropathologic features suggest that AD has biological subtypes, one of which causes PPA. Better appreciation of this fact should promote the inclusion of individuals with PPA and positive AD biomarkers into relevant clinical trials.
What this study adds
Evidence grade: Low
The record lists 19 participants. This study found a close but not obligatory association between logopenic primary progressive aphasia and Alzheimer's disease neuropathology, and that no language measure could reliably confirm or exclude Alzheimer's disease in these patients. It supports the idea that Alzheimer's disease has biological subtypes and that biomarkers are needed for diagnosis, but it does not test a treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Rogalski, E., Sridhar, J., Rader, B., Martersteck, A., Chen, K., Cobia, D., et al. (2016). Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features. Neurology. https://doi.org/10.1212/wnl.0000000000003165
Vancouver
Rogalski E, Sridhar J, Rader B, Martersteck A, Chen K, Cobia D, et al. Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features. Neurology. 2016. doi:10.1212/wnl.0000000000003165. PMID: 27566743.
BibTeX
@article{rogalski2016-27566743,
author = {Rogalski, E. and Sridhar, J. and Rader, B. and Martersteck, A. and Chen, K. and Cobia, D. and Thompson, C. K. and Weintraub, S. and others},
title = {{Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features}},
journal = {Neurology},
year = {2016},
doi = {10.1212/wnl.0000000000003165},
pmid = {27566743},
url = {https://doi.org/10.1212/wnl.0000000000003165}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Objective To identify features of primary progressive aphasia (PPA) associated with Alzheimer disease (AD) neuropathology.
- Results Impaired word-finding was the universal presenting complaint in the aphasic AD group.
- These and additional neuropathologic features suggest that AD has biological subtypes, one of which causes PPA.
Why it matters
This study found a close but not obligatory association between logopenic primary progressive aphasia and Alzheimer's disease neuropathology, and that no language measure could reliably confirm or exclude Alzheimer's disease in these patients. It supports the idea that Alzheimer's disease has biological subtypes and that biomarkers are needed for diagnosis, but it does not test a treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Participants19
- Evidence strengthLow
How this study scored 51/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2016 — within 20 year(s) of the newest study here |
| Sample size | 1 / 4 | 19 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 83 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.9 citations a year over 12 year(s) since 2016 |
| Impact for its field and year | 3 / 6 | Cited 7.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 2 / 4 | Cited 21 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Marsel M. Mesulam: h-index 101 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Northwestern University: institution h-index 1,592 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 27566743) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in Brain scans and imaging from nearby years
Also in Brain scans and imaging
137 studies in the library are filed under Brain scans and imaging with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Brain scans and imaging hub.